Here's the live share price of Cipla along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Cipla has gained 10.45% CAGR. Over the past year, the corresponding return has been -8.85%.
Cipla’s current P/E of 23.55x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Cipla | -0.06 | -0.32 | -12.65 | -15.79 | -8.85 | 14.83 | 10.45 |
| Sun Pharmaceutical Industries | 2.36 | 6.44 | 1.71 | 12.92 | 8.87 | 24.13 | 24.37 |
| Divi's Laboratories | -1.16 | 1.64 | -2.13 | 4.37 | 11.02 | 31.47 | 12.36 |
| Torrent Pharmaceuticals | 1.98 | 8.77 | 17.16 | 24.48 | 43.38 | 43.34 | 29.23 |
| Dr. Reddy's Laboratories | 0.53 | 3.57 | 3.15 | 0.27 | 19.43 | 14.61 | 8.31 |
| Lupin | 0.97 | 6.55 | 11.39 | 15.29 | 19.84 | 53.25 | 17.55 |
| Zydus Lifesciences | 0.33 | -0.36 | -1.25 | -12.19 | 3.20 | 25.38 | 15.70 |
| Mankind Pharma | -0.87 | 6.12 | 1.22 | -14.49 | 1.69 | 15.71 | 9.15 |
| Aurobindo Pharma | 7.14 | 13.46 | 10.02 | 19.98 | 18.65 | 43.08 | 9.14 |
| Alkem Laboratories | -1.88 | -7.14 | -3.40 | -0.13 | 14.52 | 21.02 | 14.43 |
| Glenmark Pharmaceuticals | 7.10 | 11.10 | 14.49 | 6.07 | 59.05 | 74.46 | 36.39 |
| Biocon | 1.58 | 4.65 | 1.56 | 7.56 | 20.83 | 21.63 | -0.39 |
| Abbott India | -3.33 | -0.04 | -4.59 | -13.85 | -10.56 | 9.70 | 12.79 |
| Laurus Labs | -0.32 | 2.32 | 2.72 | 16.38 | 78.44 | 50.82 | 23.49 |
| GlaxoSmithKline Pharmaceuticals | 1.18 | -5.98 | -3.49 | -9.64 | -6.52 | 24.59 | 11.56 |
| Ipca Laboratories | 3.98 | 5.70 | 6.30 | 18.62 | 18.43 | 25.35 | 9.82 |
| Ajanta Pharma | 4.82 | 7.92 | 17.20 | 20.92 | 22.52 | 36.75 | 20.62 |
| Anthem Biosciences | -3.60 | -8.61 | -8.12 | -22.91 | -12.05 | -4.19 | -2.54 |
| J B Chemicals & Pharmaceuticals | 2.78 | 11.73 | 18.23 | 25.18 | 41.44 | 29.68 | 28.43 |
| Emcure Pharmaceuticals | 4.23 | 3.71 | 5.12 | 12.28 | 63.36 | 3.65 | 2.18 |
Over the last one year, Cipla has declined 8.85% compared to peers like Sun Pharmaceutical Industries (8.87%), Divi's Laboratories (11.02%), Torrent Pharmaceuticals (43.38%). From a 5 year perspective, Cipla has underperformed peers relative to Sun Pharmaceutical Industries (24.37%) and Divi's Laboratories (12.36%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,323.73 | 1,329.62 |
| 10 | 1,334.8 | 1,331.75 |
| 20 | 1,337.25 | 1,337.42 |
| 50 | 1,376.89 | 1,372.98 |
| 100 | 1,453.22 | 1,420.13 |
| 200 | 1,487.11 | 1,457.27 |
In the latest quarter, Cipla remained same as its previous close in promoter holding, while DII stake increased to 30.72%, FII holding fell to 23.93%, and public shareholding moved up to 16.12% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 2,10,00,000 | 2.85 | 2,780.4 | |
| 76,35,011 | 3.84 | 1,010.88 | |
| 60,98,542 | 2.53 | 807.45 | |
| 55,00,126 | 1.21 | 728.22 | |
| 47,42,991 | 9.43 | 627.97 | |
| 38,36,985 | 1.04 | 508.02 | |
| 35,50,000 | 0.83 | 470.02 | |
| 34,95,054 | 5.88 | 462.75 | |
| 33,50,000 | 3.62 | 443.54 | |
| 32,19,459 | 0.85 | 426.26 |
* Excluding Index & Arbitrage Funds
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Date Time | Announcement |
|---|---|
| Mar 03, 2026, 1:37 AM IST | Cipla - Announcement under Regulation 30 (LODR)-Acquisition |
| Mar 03, 2026, 1:00 AM IST | Cipla - Announcement under Regulation 30 (LODR)-Acquisition |
| Feb 26, 2026, 10:51 PM IST | Cipla - Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) R |
| Feb 24, 2026, 2:23 AM IST | Cipla - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot |
| Feb 21, 2026, 11:23 PM IST | Cipla - Update On US Food And Drug Administration (USFDA) Inspection On Pharmathen International S.A. |
Cipla Ltd. is a Public Limited Listed company incorporated on 17/08/1935 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1935PLC002380 and registration number is 002380. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 19044.85 Cr. and Equity Capital is Rs. 161.52 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Cipla is ₹1,325.25 as on Mar 12, 2026.
The Cipla is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Cipla is ₹107,051.13 Cr as on Mar 12, 2026.
Today’s highest and lowest price of Cipla are ₹1,341.00 and ₹1,318.70.
The 52-week high/low is the highest and lowest price at which Cipla stock has traded in the past 52-week or nearly a year. The 52-week high of Cipla is ₹1,672.20 and 52-week low of Cipla is ₹1,283.00 as on Mar 12, 2026.
The Cipla has shown returns of -0.35% over the past day, -0.32% for the past month, -12.65% over 3 months, -8.85% over 1 year, 14.83% across 3 years, and 10.45% over 5 years.
P/E ratio of and PB ratio of Cipla are 23.55 and 3.19 on Mar 12, 2026. While the company gives a dividend yield of 1.21 per annum.